United Kingdom Microfluidics Market Size, Share, and COVID-19 Impact Analysis, By Product (Microfluidic-based Devices, Microfluidic Components), By Technology (Lab-on-a-chip, Organ-on-a-chip, Continuous Flow Microfluidics, Optofluidics & Microfluidic, Acoustofluidics & Microfluidics, Electrophoresis & Microfluidics), and UK Microfluidics Market Insights, Industry Trend, Forecasts to 2035.

United Kingdom Microfluidics Market Forecasts to 2035

• The United Kingdom Microfluidics Market Size Was Estimated at USD 1,054.2 Million in 2024
• The UK Microfluidics Market Size is Expected to Grow at a CAGR of around 11.16% from 2025 to 2035
• The UK Microfluidics Market Size is Expected to Reach USD 3,374.5 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Microfluidics Market Size is anticipated to reach USD 3,374.5 Million by 2035, growing at a CAGR of 11.16% from 2025 to 2035. The UK microfluidics market is growing due to rising demand for point-of-care diagnostics, technological advancements like lab-on-a-chip and AI integration, and increased R&D investment by pharmaceutical and biotech companies for applications in drug development, genetic analysis, and medical testing.

Market Overview

The UK microfluidics market includes a flexible technology for the control of small volumes of fluids, delivering accuracy, sensitivity, and specificity through the use of microchannels. Microfluidics technology is commonly used in pharmaceuticals and healthcare because it can be used to conduct point-of-care testing or when connected with PCR, and since it can enable common applications in the industry, including DNA and RNA analysis, cell separation, and immunoassays. Microfluidics can also connect various interdisciplinary technologies within diagnostics and molecular biology based on a relatively new form of automation, multiplexing, and high-throughput screening.

Microfluidics developments are enabling faster, more accurate, and more efficient testing, which is revolutionising diagnostic healthcare. The need for prehospital diagnostic tools, like at-home blood glucose monitoring, has increased due to rising hospital expenses and more frequent patient visits. Microfluidics-powered Point-of-Care (POC) devices, with features including minimally invasive sampling and fast turnaround times, promote early disease identification and improved patient outcomes. The adoption of microfluidics was further spurred by the COVID-19 pandemic, as small PoCT devices were crucial for prompt, precise diagnostics with high sensitivity and specificity. By analysing tiny fluid quantities, these instruments also lessen sample waste and reagent consumption. With numerous businesses creating cutting-edge technology and prototypes for commercialisation, innovation in microfluidics-based IVD solutions is still expanding. In addition to growing lab-on-a-chip technologies and microfluidic sensors, in research and clinical diagnostics, the microfluidics market is expanding significantly due to technological developments, early diagnosis, and the need for better diagnostic devices.

Report Coverage

This research report categorizes the market for the UK microfluidics market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom microfluidics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom microfluidics market.

Driving Factors

The increase in demand for point-of-care testing, technical advances, and an increased number of chronic diseases, the market for microfluidic devices in the UK is advancing at speed. Microfluidics is promoted by organizations such as the NIH and WHO, accelerating tests and improving accuracy, especially in low-resource settings. The push for innovation is propelled by investments in the healthcare sector and improvements to the infrastructure, especially in the EU, which promotes better healthcare delivery by tackling the adoption of new/advanced microfluidic technologies. The major companies are invested in pushing innovation in microfluidics.

Restraining Factors

The high costs and complexities are associated with device fabrication/integration. There is a low level of standardisation, and challenges with production ramp-up can limit the diffusion of microfluidics. More broadly, there are the obstacles of operational and maintenance expertise, regulatory issues, the long approval process, and approval timelines; all these factors can limit the adoption of new devices and slow market growth, especially for smaller firms. These factors hamper the microfluidics market during the forecast period.

Market Segmentation

The United Kingdom microfluidics market share is classified into product and technology.

• The microfluidic components segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom microfluidics market is segmented by product into microfluidic-based devices, microfluidic components. Among these, the microfluidic components segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The fluidic control of small volume delivery for analytical, medication administration, and diagnostic purposes relies on microfluidic components such as pumps, valves, chips, and sensors. The market is growing due to increased demand for lab-on-a-chip platforms, point-of-care diagnostics, and personalized medicine. Emerging technology and scalable methods of manufacturing components, such as 3D printing and soft lithography, along with increased spending on biomedical R&D, all help facilitate adoption

• The lab-on-a-chip segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom microfluidics market is segmented by technology into lab-on-a-chip, organ-on-a-chip, continuous flow microfluidics, optofluidics & microfluidic, acoustofluidics & microfluidics, electrophoresis & microfluidics. Among these, the lab-on-a-chip segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. In cell biology, lab-on-a-chip research has lately shown promise. These systems demonstrate the ability to swiftly handle a large number of cells while controlling them at the single-cell level. For example. To bridge the gap between laboratory work and clinical practice, the study emphasised the significance of enhanced accessibility, usability, and manufacturability. To fully realise the potential of microfluidic devices in diagnostics and personalised medicine, the authors offered techniques to help ease their transition to the clinic.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom microfluidics market and a with comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Dolomite Microfluidics (Unchained Labs)
• Sphere Fluidics
• Epigem
• uFluidix
• Illumina
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Thermo Fisher Scientific
• Danaher Corporation
• Roche
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom microfluidics market based on the below-mentioned segments:

United Kingdom Microfluidics Market, By Product

• Microfluidic-based Devices
• Microfluidic Components

United Kingdom Microfluidics Market, By Technology

• Lab-on-a-chip
• Organ-on-a-chip
• Continuous Flow Microfluidics
• Optofluidics & Microfluidic
• Acoustofluidics & Microfluidics
• Electrophoresis & Microfluidics